DepoMed, Inc. (NASDAQ:DEPO)
A specialty pharmaceutical company focused on the development and commercialization of differentiated products that address growing markets and are based on proprietary oral drug delivery technologies.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Biotoday
(31.51)
Submitted: 10/7/2010 3:42:17 PM :
Start Price:
$4.62
DEPO Score:
+4.84
On the verge
Recs
yellowear
(< 20)
Submitted: 5/9/2010 12:29:14 PM :
Start Price:
$2.45
DEPO Score:
+104.35
When all the bad news is out and the stock has oversold below $2.50, that's when I bought with real money and expect in 5 years to be more than a 5 bagger.
Just about perfect trade!
Recs
ecapital
(< 20)
Submitted: 5/2/2010 10:33:53 AM :
Start Price:
$4.04
DEPO Score:
+25.24
Great pipeline potential.<br />Cash flow positive wi 18-24 months.<br />Huge earnings potential.
Recs
ssbb123
(53.25)
Submitted: 2/22/2010 3:16:36 PM :
Start Price:
$2.46
DEPO Score:
-104.59
"Cancer risk" can't see this being a good investment for the next few months at least.
http://www.forbes.com/2010/02/18/xenoport-glaxosmithkline-depomed-markets-equities-pharmaceuticals.html?partner=yahootix
Recs
crapsshooter
(97.05)
Submitted: 2/6/2009 7:49:23 PM :
Start Price:
$2.40
DEPO Score:
+74.16
I have been involved with this stock for awhile now and it has continued to increase in value slowly. the pace over the last week has quickened and I look for it to continue. Sales continue to rise and new products are being developed and licensed. I am begining to look at this company as a buy out caindidate for one of the big pharco's
Recs
NASAGeek
(86.10)
Submitted: 6/26/2008 9:21:55 PM :
Start Price:
$3.39
DEPO Score:
+55.79
magicformulainvesting.com screen at $153M market cap, top 25 companies on June 26, 2008
Recs
Gurdjeppo
(90.80)
Submitted: 5/27/2008 4:11:32 PM :
Start Price:
$4.32
DEPO Score:
+34.55
It's Depo-tastic!
Recs
REDSOXFANFORLIFE
(84.00)
Submitted: 3/12/2008 8:10:14 PM :
Start Price:
$2.69
DEPO Score:
+97.87
Appears to be headed in the right direction. A portion of 2007 gains came from terminating promotion agreement with King Pharmaceuticals. However, sales and income numbers are on the rise. I'm taking a risk and keeping my fingers crossed
Recs
ESCalanderAI
(59.83)
Submitted: 3/3/2008 7:38:25 AM :
Start Price:
$3.37
DEPO Score:
+59.51
EXP POS EARN
Recs
JCash22
(85.64)
Submitted: 2/7/2008 10:42:29 AM :
Start Price:
$3.25
DEPO Score:
+65.18
good fundamentals.
Recs
esso02
(37.76)
Submitted: 12/31/2007 3:39:52 PM :
Start Price:
$3.29
DEPO Score:
-73.20
Unknowen till FDA approval thoght it received a lot of $ due to
Recs
pjhurren
(< 20)
Submitted: 7/10/2007 7:13:33 PM :
Start Price:
$5.00
DEPO Score:
+18.69
Wow just went down 60%. haha
see if they bounce back?
Recs
Mattd46612
(85.25)
Submitted: 7/9/2007 11:04:47 PM :
Start Price:
$1.90
DEPO Score:
+197.64
Just a matter of time before it blows up..
Recs
Brxcqqq
(27.82)
Submitted: 6/14/2007 12:04:40 PM :
Start Price:
$5.11
DEPO Score:
-15.86
negative earnings, negative cash flow, can't understand for the life of me why this is a ***** stock. now watch me gets burned as it adds 160% in the next three weeks :-)
Recs
GrabBagGuy
(23.23)
Submitted: 6/11/2007 4:17:01 PM :
Start Price:
$4.31
DEPO Score:
+34.69
I found this stock in December of 2006 when it was at $2.92 a share. Their product is unique and marketable and while the ride up (and down and up agian) can be frustrating I have it down as $6 per share before Christmas.
Recs
midbulllongbull
(27.27)
Submitted: 6/10/2007 9:33:26 PM :
Start Price:
$4.32
DEPO Score:
+34.55
volatile 10~30%
Recs
dgoldmeier
(20.71)
Submitted: 4/14/2007 9:27:18 AM :
Start Price:
$3.99
DEPO Score:
+41.83
A small pharma with good tech,pipeline, and patents.
Recs
wincopr
(57.27)
Submitted: 12/1/2006 12:08:06 PM :
Start Price:
$3.42
DEPO Score:
+60.44
Great choice to invest. New drug will become pop.
Recs
coalcentury7
(65.02)
Submitted: 10/25/2006 10:00:12 PM :
Start Price:
$4.32
DEPO Score:
+26.00
2 approved drugs, but the prize will be gabapentine GR (hope i spelled that right). Its a drug that deals with pain related to diabetes (a few other things as well, but this is the big market.) gabapentine is out in the market now (Pfizer i think) but requires the user to take it 3 or 4 times a day. GR will be a one a day drug. Forgoten by the market, approval is a couple years away. For specifics google wr hambrecht then go to research and you will find it under specialty pharma. good luck. (no matter what anybody says, we could all use it :)
Recs
ztur2218
(< 20)
Submitted: 10/6/2006 11:49:35 AM :
Start Price:
$4.35
DEPO Score:
+21.49
very good potential with recent drug glumteza
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 21 - 40 of 40 : « Previous 1 2